Hikma Pharmaceuticals Share News (HIK)

Regulatory Approval Of Hikma's Colchicine Capsule Upheld By US Court

Britain's FTSE climbs to 11-month closing high as insurers rise

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 rises 0.5 pct to 6,728.99 points * Healthcare stocks among top gainers * Admiral Group rises after upgrade, L&G up as

Hikma Pharmaceuticals launches generic cancer tablets in US

(ShareCast News) - Hikma Pharmaceuticals said its wholly-owned US affiliate, West-Ward Pharmaceuticals has launched generic cancer treatment tablets in the US. The Capecitabine tablets, which are the generic equivalents to Xeloda tablets, are indicated for adjuvant treatment in patients with Dukes'

WINNERS & LOSERS SUMMARY: Man Group Down As CEO Departs For PIMCO

Britain's FTSE rallies though miners lag

(ADVISORY- Follow European and UK stock markets in real time on the Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets) * FTSE 100 up 0.4 pct * Healthcare stocks among top gainers * Admiral Group rises after upgrade * Miners fall on disappoint

LONDON MARKET OPEN: Stocks Mixed As Miners Limit FTSE 100 Gains

TOP NEWS: Hikma Pharmaceuticals Launches Xeloda Tablets In US

BROKER RATINGS SUMMARY: HSBC Downgrades Hikma To Hold From Buy

LONDON MARKET OPEN: RPC Profit Comes Ahead Of Its Expectations

LONDON MARKET CLOSE: Shares Mixed As Pound Falls To Near USD1.30

BROKER RATINGS SUMMARY: Jefferies And Liberum Downgrade UK Retailers

European healthcare first sector to recover Brexit losses

LONDON, June 29 (Reuters) - The rush to large-cap, high quality, dividend-paying pharmaceutical stocks in the aftermath of Brexit has helped Europe's healthcare index erase all its losses since last week's vote. The healthcare index, up 1.4 percent on Wednesday, is the only regional sector

Directors dealings: Hikma chief dips back in after gout victory

(ShareCast News) - Hikma Pharmaceuticals chief executive Said Darwazah has further boosted his stake in the company with a huge £3.3m purchase of shares. Darwazah, whose father set up Hikma in 1978, showed his confidence in the company with a purchase of 150,000 shares at a price of 2,200p, al

FTSE quarterly review confirms raft of changes to 100 and 250 indices

(ShareCast News) - Hikma Pharmaceuticals' promotion to the FTSE 100 index was confirmed after the latest quarterly review was announced overnight, while demoted blue chip Inmarsat was joined in the FTSE 250 by three recently floated finance groups CYBG, CMC Markets and Metro Bank plus several others

Hikma to replace Inmarsat in FTSE 100 index

LONDON, June 1 (Reuters) - Hikma Pharmaceuticals will be promoted to Britain's benchmark FTSE 100 equity index after a sharp rally in its shares since March, while satellite company Inmarsat will drop out of the FTSE. A spokesman for the London Stock Exchange announced the change via telep